Overview


According to FutureWise analysis the market for microfluidics in 2023 is US$ 25.25 billion, and is expected to reach US$ 68.17 billion by 2031 at a CAGR of 13.22%.

The global microfluidics market growth is steered by the growing insistence for point-of-care (POC) testing, rising prevalence of persistent diseases, quicker turn-around analysis time and improvements in device portability. Point-of-care testing permits healthcare professionals to conduct the patient diagnosis in an ambulance, the physician’s office, at field, hospital or at home. Devices assisted with microfluidic technology are currently deployed for point-of–care testing owing to their requirement of small sample volumes and they use channels that are micro-fabricated for analysing samples. Devices used for POC testing are already widely used in blood, HIV, glucose and haemoglobin testing sectors. The POC testing devices of the future would possibly emphasize on cancer and antibiotics therapies. The POC testing devices that are based on the microfluidic technique have massive potential in the developed as well as developing nations, owing to the high amount of population affected by such diseases.

The clinical diagnostics segment is likely to hold the largest global microfluidics market share and is predicted to exhibit a substantial growth rate over the forecast time frame. A substantial area of application for microfluidics is clinical diagnostics. Diseases, for instance, toxicity, can be identified by undertaking multiple biochemical analysis procedures and by symptom observation. The changes occurring in the blood of the patients can signify organ dysfunction or damage, before observable damages of the microscopic cells or other kinds of symptoms.

There has been an increase in the insistence for the development of an inexpensive and easy-to-handle biochip for clinical diagnostics by using plastic microfluidic chips that are fully integrated and which have the identifying or sampling capability of reliable and fast metabolic parameter measurements from a patient and that too with no or minimal invasion. Therefore, the augmentation of clinical diagnostics is predicted to aid the expansion of the global microfluidics market size.

The North America region accounts the largest microfluidics market share and it is predicted to continue its domination over the forecast period. This is credited to factors, for instance, the better reimbursement policies coupled with a well-established healthcare system and the higher adoption rate of advanced therapies amongst the population. Microfluidics is growing at a meteoric pace, especially in the U.S, with respect to massive budget sanctions for research and development. Point-of-care and molecular diagnostics primarily use microfluidic techniques for multiple applications, and thus, they account a large market share in the U.S. Due to this, the U.S holds most of the market share in the North American region.

  • Danaher Corporation
  • Thermo Fisher Scientific
  • PerkinElmer Inc.
  • Agilent Technologies
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche
  • Illumina, Inc.
  • Fluidigm Microfluidics
  • Abbott Laboratories
  • Qiagen
  • Parker-Hannifin Corporation
  • Fluigent SA
  • Idex Corporation
  • Camozzi Automation Spa Società Unipersonale
  • Gems Sensors and Control
  • Aignep S.P.A.
  • SMC Corporation
  • Dolomite Microfluidics
  • Cellix Ltd.
  • Elveflow
  • Microfluidic ChipShop
  • Micronit Microtechnologies
  • MicroLiquid

(Note: The list of the major players will be updated with the latest market scenario and trends

By Product

  • Microfluidic-based Devices
  • Microfluidic Components
    • Microfluidic chips
    • Flow and pressure sensors
    • Flow and pressure controllers
    • Micropumps
    • Microfluidic valves
    • Microneedles
    • Other components

By Application

  • In Vitro Diagnostics
    • PoC Testing
    • Clinical Diagnostics
    • Veterinary Diagnostics
  • Pharmaceutical, Life Science Research, and Manufacturing
    • Lab Analytics
      • Proteomic Analysis
      • Genomic Analysis
      • Cell-based Assays
      • Capillary Electrophoresis
    • Microdispensing
    • Microreaction
  • Therapeutics
    • Drug Delivery
    • Wearable Devices

By End User

  • Hospitals and Diagnostic Centers
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Microfluidics Market By Product, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Microfluidics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Microfluidics Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Microfluidics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Microfluidics Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Microfluidic-based Devices
        2. Microfluidic Components
         2.1. Microfluidic chips
         2.2. Flow and pressure sensors
         2.3. Flow and pressure controllers
         2.4. Micropumps
         2.5. Microfluidic valves
         2.6. Microneedles
         2.7. Other components

  • 8.   Global Microfluidics Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. In Vitro Diagnostics
         1.1. PoC Testing
         1.2. Clinical Diagnostics
         1.3. Veterinary Diagnostics
        2. Pharmaceutical, Life Science Research, and Manufacturing
         2.1. Lab Analytics
          2.1.1. Proteomic Analysis
          2.1.2. Genomic Analysis
          2.1.3. Cell-based Assays
          2.1.4. Capillary Electrophoresis
         2.2. Microdispensing
         2.3. Microreaction
        3. Therapeutics
         3.1. Drug Delivery
         3.2. Wearable Devices

  • 9.   Global Microfluidics Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals and Diagnostic Centers
        2. Academic and Research Institutes
        3. Pharmaceutical and Biotechnology Companies

  • 10.   North America Microfluidics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Microfluidics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Microfluidics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Microfluidics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Danaher Corporation
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Thermo Fisher Scientific
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. PerkinElmer Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Agilent Technologies
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bio-Rad Laboratories, Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Becton, Dickinson and Company
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. F. Hoffmann-La Roche
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Illumina, Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Fluidigm Microfluidics
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Abbott Laboratories
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Qiagen
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Parker-Hannifin Corporation
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Fluigent SA
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Idex Corporation
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Camozzi Automation Spa Società Unipersonale
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Gems Sensors and Control
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Aignep S.P.A.
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. SMC Corporation
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Dolomite Microfluidics
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Cellix Ltd.
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21. Elveflow
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview
        22. Microfluidic ChipShop
         22.1. Company Overview
         22.2. Product Portfolio
         22.3. SWOT Analysis
         22.4. Financial Overview
         22.5. Strategic Overview
        23. Micronit Microtechnologies
         23.1. Company Overview
         23.2. Product Portfolio
         23.3. SWOT Analysis
         23.4. Financial Overview
         23.5. Strategic Overview
        24. MicroLiquid
         24.1. Company Overview
         24.2. Product Portfolio
         24.3. SWOT Analysis
         24.4. Financial Overview
         24.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients